title: Mechanisms of synergism between gemcitabine and cisplatin.
authors.affiliation: Department of Medical Oncology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands.
authors.forename: C J
authors.initials: CJ
authors.lastname: van Moorsel
authors.forename: G
authors.initials: G
authors.lastname: Veerman
authors.forename: J B
authors.initials: JB
authors.lastname: Vermorken
authors.forename: D A
authors.initials: DA
authors.lastname: Voorn
authors.forename: J R
authors.initials: JR
authors.lastname: Kroep
authors.forename: A M
authors.initials: AM
authors.lastname: Bergman
authors.forename: H M
authors.initials: HM
authors.lastname: Pinedo
authors.forename: G J
authors.initials: GJ
authors.lastname: Peters
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000493:pharmacokinetics / Q000633:toxicity*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002945:Cisplatin / Q000009:adverse effects / Q000633:toxicity*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000633:toxicity; D004357:Drug Synergism; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms; D012334:RNA, Neoplasm / Q000096:biosynthesis; D014407:Tumor Cells, Cultured; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D003841:Deoxycytidine; D002945:Cisplatin; D000093542:Gemcitabine